Literature DB >> 33493480

Verification and Validation of Computational Models Used in Biopharmaceutical Manufacturing: Potential Application of the ASME Verification and Validation 40 Standard and FDA Proposed AI/ML Model Life Cycle Management Framework.

Gautier Bideault1, Anthony Scaccia2, Thomas Zahel3, Robert W Landertinger4, Chathuri Daluwatte5.   

Abstract

A wide variety of computational models covering statistical, mechanistic, and machine learning (locked and adaptive) methods are explored for use in biopharmaceutical manufacturing. Limited discussion exists on how to establish the credibility of a computational model for application in biopharmaceutical manufacturing. In this work, we tried to use the American Society of Mechanical Engineers (ASME) Verification and Validation 40 (V&V 40) standard and FDA proposed AI/ML model life cycle management framework for Software as a Medical Device (SaMD) in biopharmaceutical manufacturing use cases, by applying to a set of curated hypothetical examples. We discussed the need for standardized frameworks to facilitate consistent decision making to enable efficient adoption of computational models in biopharmaceutical manufacturing and alignment of existing good practices with existing frameworks. In the study of our examples, we anticipate existing frameworks like V&V 40 can be adopted.
Copyright © 2021 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Keywords:  Biopharmaceutical manufacturing; Computational models; Digital twins; GMLP; Machine learning; Verification and validation

Year:  2021        PMID: 33493480     DOI: 10.1016/j.xphs.2021.01.016

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  1 in total

1.  Bayesian Augmented Clinical Trials in TB Therapeutic Vaccination.

Authors:  Dimitrios Kiagias; Giulia Russo; Giuseppe Sgroi; Francesco Pappalardo; Miguel A Juárez
Journal:  Front Med Technol       Date:  2021-10-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.